Brian Varnum
No más puestos en curso
Fortuna: 98 605 $ al 30/04/2024
Historial de carrera de Brian Varnum
Antiguos cargos conocidos de Brian Varnum.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 02/08/2021 | 11/07/2023 |
| Director Ejecutivo | 02/08/2021 | 11/07/2023 | |
| Presidente | 09/05/2019 | 02/08/2021 | |
C3 Jian LLC
 C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Corporate Officer/Principal | 01/03/2012 | 01/05/2019 |
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | Corporate Officer/Principal | 01/01/2012 | - |
Formación de Brian Varnum.
| University of California | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ARMATA PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
C3 Jian LLC
C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Health Technology |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Brian Varnum
- Experiencia
